Chan I, Ewald A
J Clin Invest. 2022; 132(6).
PMID: 35289318
PMC: 8920322.
DOI: 10.1172/JCI143762.
Sungur C, Murphy W
Crit Rev Oncog. 2014; 19(1-2):57-66.
PMID: 24941373
PMC: 4242411.
DOI: 10.1615/critrevoncog.2014010805.
Toth F, Zdravkovic M, Ebbesen P
Clin Diagn Lab Immunol. 1994; 1(6):650-9.
PMID: 8556516
PMC: 368383.
DOI: 10.1128/cdli.1.6.650-659.1994.
Wang E, Perera P, Fisher J, Borysiewicz L
Clin Exp Immunol. 1993; 94(2):297-305.
PMID: 7693383
PMC: 1534246.
DOI: 10.1111/j.1365-2249.1993.tb03447.x.
Auer I, Ziemer E, Sommer H
Clin Exp Immunol. 1980; 42(1):41-9.
PMID: 7460390
PMC: 1537072.
Spontaneous cytotoxicity of rheumatoid and normal peripheral blood mononuclear cells against 4 human lymphoblastoid cell lines.
Highton J, Panayi G
Ann Rheum Dis. 1980; 39(6):559-62.
PMID: 7458432
PMC: 1000620.
DOI: 10.1136/ard.39.6.559.
Isolation of human spontaneous killer lymphocytes by bacterial adherence.
Kleinman R, De Boer K, Teodorescu M
Clin Exp Immunol. 1980; 39(2):510-8.
PMID: 7389207
PMC: 1538050.
The immunological profile of mycosis fungoides.
Jensen J, Thestrup-Pedersen K, Ahrons S, Zachariae H
Clin Exp Immunol. 1982; 50(2):397-405.
PMID: 6983938
PMC: 1536693.
Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes.
Moore M, Taylor G, White W
Cancer Immunol Immunother. 1982; 13(1):56-61.
PMID: 6961951
PMC: 11039274.
DOI: 10.1007/BF00200202.
In vitro stimulation of cell-mediated cytotoxicity by acute leukaemias.
Taylor G
Br J Cancer. 1981; 43(2):157-68.
PMID: 6451236
PMC: 2010526.
DOI: 10.1038/bjc.1981.24.
Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
PRINCE H, Ettenger R, Dorey F, Fine R, Fahey J
J Clin Immunol. 1984; 4(4):312-8.
PMID: 6378956
DOI: 10.1007/BF00915299.
Modulation of human natural killer cell activity by pharmacological mediators.
Hall T, Chen S, Brostoff J, Lydyard P
Clin Exp Immunol. 1983; 54(2):493-500.
PMID: 6317242
PMC: 1535881.
Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
Klein E, Masucci M
Springer Semin Immunopathol. 1982; 5(1):63-73.
PMID: 6314570
DOI: 10.1007/BF00201957.
Increased sensitivity to natural killing in Raji cells is due to effector recognition of molecules appearing on target cell membranes following EBV cycle induction.
Blazar B, Fitzgerald J, Sutton L, Strome M
Clin Exp Immunol. 1983; 54(1):31-8.
PMID: 6311470
PMC: 1536181.
Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients.
Winston D, Ho W, Schroff R, Champlin R, Gale R
Antimicrob Agents Chemother. 1983; 23(6):846-51.
PMID: 6311088
PMC: 184981.
DOI: 10.1128/AAC.23.6.846.
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
Patel P, Dorval G, Menezes J
Infect Immun. 1982; 38(1):251-9.
PMID: 6292093
PMC: 347726.
DOI: 10.1128/iai.38.1.251-259.1982.
Herpesvirus ateles and herpesvirus saimiri transform marmoset T cells into continuously proliferating cell lines that can mediate natural killer cell-like cytotoxicity.
Johnson D, Jondal M
Proc Natl Acad Sci U S A. 1981; 78(10):6391-5.
PMID: 6273869
PMC: 349045.
DOI: 10.1073/pnas.78.10.6391.
T cell chronic lymphocytic leukaemia with suppressor phenotype.
Hofman F, Smith D, Hocking W
Clin Exp Immunol. 1982; 49(2):401-9.
PMID: 6215199
PMC: 1536481.
Recruitment of OKM1 staining lymphocytes with selective binding to K-562 tumour targets by interferon.
Salata R, Schacter B, Ellner J
Clin Exp Immunol. 1983; 52(1):185-90.
PMID: 6190593
PMC: 1535559.
Lymphocyte-mediated lysis of tumor cells in vitro. Antigen-restricted clonal and unrestricted polyclonal effects.
Klein E
Springer Semin Immunopathol. 1982; 5(2):147-59.
PMID: 6183765
DOI: 10.1007/BF00199793.
